MB-107 Annamycin II Sarcoma
Clinical Trial Grant
Awarded By
Moleculin Biotech, Inc.
Start Date
March 3, 2021
End Date
April 1, 2024
Awarded By
Moleculin Biotech, Inc.
Start Date
March 3, 2021
End Date
April 1, 2024